Functional Gastrointestinal Disorders
Conditions
Brief summary
This is a quality improvement health services study in the Division of Gastroenterology at Beth Israel Deaconess Medical Center (BIDMC).
Detailed description
The purpose of this study is to evaluate patients' reported experiences with regularly prescribed medications. No medications are prescribed as part of this study. Rather, if a patient are prescribed a new medication during their regularly scheduled clinic visit, he/she may be eligible to participate. Patients who agree to participate and who are prescribed a medication in clinic will be contacted by telephone or email 3 weeks after their appointment to evaluate positive and negative experiences with the medication.
Interventions
OTHERStandard of Care
The intervention involves clinician-provided information to patients receiving a new medication as part of their standard medical care. Intervention 1 includes more detailed information compared to Intervention 2.
Sponsors
Beth Israel Deaconess Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patient is seen in the Division of Gastroenterology at BIDMC * Patient is prescribed a medication for the treatment of functional gastrointestinal disorders that has not previously been tried by the patient
Exclusion criteria
* Patient is not seen in the Division of Gastroenterology at BIDMC * Patient has previously taken the drug that is prescribed
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient-reported benefit from the drug | 3 weeks after the physician visit | Visual Analog Scale of reported benefit from the drug (0-10) |
| Number of side effects reported from the drug | 3 weeks after the physician visit | Checklist of reported side effects from the drug |
Countries
United States
Outcome results
None listed